Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

USH2A Gene Editing Using the CRISPR System
Carla Fuster‐García, Gema García‐García, Elisa González‐Romero, et al.
Molecular Therapy — Nucleic Acids (2017) Vol. 8, pp. 529-541
Open Access | Times Cited: 61

Showing 1-25 of 61 citing articles:

Gene editing and CRISPR in the clinic: current and future perspectives
Matthew P. Hirakawa, Raga Krishnakumar, Jerilyn A. Timlin, et al.
Bioscience Reports (2020) Vol. 40, Iss. 4
Open Access | Times Cited: 168
Inherited retinal diseases: Linking genes, disease-causing variants, and relevant therapeutic modalities
Nina Schneider, Yogapriya Sundaresan, Prakadeeswari Gopalakrishnan, et al.
Progress in Retinal and Eye Research (2021) Vol. 89, pp. 101029-101029
Closed Access | Times Cited: 129
The genetic and phenotypic landscapes of Usher syndrome: from disease mechanisms to a new classification
Sedigheh Delmaghani, A. Amraoui
Human Genetics (2022) Vol. 141, Iss. 3-4, pp. 709-735
Open Access | Times Cited: 76
Usher syndrome: clinical features, molecular genetics and advancing therapeutics
Maria Toms, Waheeda Pagarkar, Mariya Moosajee
Therapeutic Advances in Ophthalmology (2020) Vol. 12
Open Access | Times Cited: 85
USH2A-retinopathy: From genetics to therapeutics
Lyes Toualbi, Maria Toms, Mariya Moosajee
Experimental Eye Research (2020) Vol. 201, pp. 108330-108330
Open Access | Times Cited: 81
New molecular therapies for the treatment of hearing loss
Yutian Ma, Andrew K. Wise, Robert K. Shepherd, et al.
Pharmacology & Therapeutics (2019) Vol. 200, pp. 190-209
Open Access | Times Cited: 74
Disease mechanisms and gene therapy for Usher syndrome
Gwenaelle G.S. Géléoc, A. Amraoui
Hearing Research (2020) Vol. 394, pp. 107932-107932
Open Access | Times Cited: 70
Genome Editing in Patient iPSCs Corrects the Most Prevalent USH2A Mutations and Reveals Intriguing Mutant mRNA Expression Profiles
Carla Sanjurjo-Soriano, Nejla Erkilic, David Baux, et al.
Molecular Therapy — Methods & Clinical Development (2019) Vol. 17, pp. 156-173
Open Access | Times Cited: 66
Whole genome sequencing for USH2A-associated disease reveals several pathogenic deep-intronic variants that are amenable to splice correction
Janine Reurink, Nicole Weisschuh, Alejandro Garanto, et al.
Human Genetics and Genomics Advances (2023) Vol. 4, Iss. 2, pp. 100181-100181
Open Access | Times Cited: 19
Gene Therapy for Retinitis Pigmentosa: Current Challenges and New Progress
Yu‐Chen Liu, Xin Zong, Wenye Cao, et al.
Biomolecules (2024) Vol. 14, Iss. 8, pp. 903-903
Open Access | Times Cited: 7
Genetics, pathogenesis and therapeutic developments for Usher syndrome type 2
Merel Stemerdink, Belén García‐Bohórquez, Renske Schellens, et al.
Human Genetics (2021) Vol. 141, Iss. 3-4, pp. 737-758
Closed Access | Times Cited: 34
Delivery strategies for CRISPR/Cas genome editing tool for retinal dystrophies: challenges and opportunities
Aayushi Lohia, Deepak Kumar Sahel, Mohd Salman, et al.
Asian Journal of Pharmaceutical Sciences (2022) Vol. 17, Iss. 2, pp. 153-176
Open Access | Times Cited: 25
Baseline Microperimetry and OCT in the RUSH2A Study: Structure−Function Association and Correlation With Disease Severity
Eleonora M. Lad, Jacque L. Duncan, Wendi Liang, et al.
American Journal of Ophthalmology (2022) Vol. 244, pp. 98-116
Open Access | Times Cited: 24
Usher Syndrome: Genetics and Molecular Links of Hearing Loss and Directions for Therapy
Meg Whatley, Abbie Francis, Zi Ying Ng, et al.
Frontiers in Genetics (2020) Vol. 11
Open Access | Times Cited: 39
Baseline Visual Field Findings in the RUSH2A Study: Associated Factors and Correlation With Other Measures of Disease Severity
Jacque L. Duncan, Wendi Liang, Maureen G. Maguire, et al.
American Journal of Ophthalmology (2020) Vol. 219, pp. 87-100
Open Access | Times Cited: 33
Gene Therapy Restores Auditory Functions in an Adult Vglut3 Knockout Mouse Model
Xingle Zhao, Huihui Liu, Hongchao Liu, et al.
Human Gene Therapy (2022) Vol. 33, Iss. 13-14, pp. 729-739
Closed Access | Times Cited: 20
Efficient correction of ABCA4 variants by CRISPR-Cas9 in hiPSCs derived from Stargardt disease patients
Laura Siles, Sheila Ruiz‐Nogales, Arnau Navinés‐Ferrer, et al.
Molecular Therapy — Nucleic Acids (2023) Vol. 32, pp. 64-79
Open Access | Times Cited: 12
Successful large gene augmentation of USH2A with non-viral episomal vectors
Maria Toms, Lyes Toualbi, Patrick Almeida, et al.
Molecular Therapy (2023) Vol. 31, Iss. 9, pp. 2755-2766
Open Access | Times Cited: 12
Guiding Lights in Genome Editing for Inherited Retinal Disorders: Implications for Gene and Cell Therapy
Carla Sanjurjo-Soriano, Vasiliki Kalatzis
Neural Plasticity (2018) Vol. 2018, pp. 1-15
Open Access | Times Cited: 33
Clinical and preclinical therapeutic outcome metrics for USH2A-related disease
Maria Toms, Adam M. Dubis, Erik de Vrieze, et al.
Human Molecular Genetics (2020) Vol. 29, Iss. 11, pp. 1882-1899
Open Access | Times Cited: 32
A Review of Gene, Drug and Cell-Based Therapies for Usher Syndrome
Lucy S. French, Carla Mellough, Fred K. Chen, et al.
Frontiers in Cellular Neuroscience (2020) Vol. 14
Open Access | Times Cited: 28
Systematic analysis of factors that improve homologous direct repair (HDR) efficiency in CRISPR/Cas9 technique
Mariateresa Di Stazio, Nicola Foschi, Emmanouil Athanasakis, et al.
PLoS ONE (2021) Vol. 16, Iss. 3, pp. e0247603-e0247603
Open Access | Times Cited: 27
Usher Syndrome in the Inner Ear: Etiologies and Advances in Gene Therapy
Evan de Joya, Brett M. Colbert, Pei-Ciao Tang, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 8, pp. 3910-3910
Open Access | Times Cited: 27
Human induced pluripotent stem cells and CRISPR/Cas-mediated targeted genome editing: Platforms to tackle sensorineural hearing loss
Miodrag Stojković, Dongjun Han, Minjin Jeong, et al.
Stem Cells (2021) Vol. 39, Iss. 6, pp. 673-696
Open Access | Times Cited: 25
The application and progression of CRISPR/Cas9 technology in ophthalmological diseases
Xumeng Hu, Beibei Zhang, Xiaoli Li, et al.
Eye (2022) Vol. 37, Iss. 4, pp. 607-617
Closed Access | Times Cited: 19
Page 1 - Next Page

Scroll to top